Biotech vet Phil Greenberg on his new cancer-fighting startup and immunotherapy’s next phase by Charlotte Schubert on March 29, 2022March 31, 2022 at 6:26 am Philip Greenberg has been trying to stop cancer for decades. With Affini-T Therapeutics, the Fred Hutchinson Cancer Research Center investigator may finally have his chance. The company announced $175 million… Read More